Canada markets closed

DNA Sep 2024 0.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.4000+0.0300 (+8.11%)
As of 10:02AM EDT. Market open.
Full screen
Previous Close0.3700
Open0.5000
Bid0.3500
Ask0.5500
Strike0.50
Expire Date2024-09-20
Day's Range0.4000 - 0.5000
Contract RangeN/A
Volume11
Open Interest360
  • PR Newswire

    Ginkgo Bioworks to Participate in Two Conferences in May

    Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that management will be participating in two investor conferences in May.

  • PR Newswire

    Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan

    Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a binding definitive agreement. Together, Sojitz and Ginkgo aim to build connections with key Japanese businesses and encourage the use of synthetic biology to develop sustainable production processes.

  • PR Newswire

    Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE

    Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity, today announced that it received a notice on May 7, 2024 from the New York Stock Exchange ("NYSE") informing the Company that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's Class A common stock was less than $1 per share over a consecutive 30 trading-day period. The no